APOE and progression of AD–combining clinical and research data

Fawzi, Waleed, Perera, Gayan, Khondoker, Mizanur ORCID: https://orcid.org/0000-0002-1801-1635, Boitsova, Tatjana, Breen, Gerome and Stewart, Robert (2014) APOE and progression of AD–combining clinical and research data. In: 6th International Conference on Alzheimers Disease and Related Disorders in the Middle East, 2013-10-25 - 2013-10-27, Istanbul.

Full text not available from this repository. (Request a copy)


Cognitive decline in Alzheimer’s disease (AD) is inevitable, but the rate of this decline varies markedly between patients. Identifying a marker for the rate-of-decline can help in predicting prognosis and allocating resources and charting the course of care with patients and their families. Apolipoprotein E gene (APOE) is an important risk factor for late-onset AD and the presence of the genotype is the most significant genetic risk factor. However, establishing a role for APOE in predicting the rate of decline has proved elusive.

Item Type: Conference or Workshop Item (Other)
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: Pure Connector
Date Deposited: 24 Sep 2016 01:08
Last Modified: 25 Aug 2022 11:10
URI: https://ueaeprints.uea.ac.uk/id/eprint/60561
DOI: 10.1016/j.neurobiolaging.2013.10.053

Actions (login required)

View Item View Item